Blade Air Mobility, Inc. engages in providing air transportation alternatives through a technology-powered and global air mobility platform. The company is headquartered in New York City, New York and currently employs 182 full-time employees. The company went IPO on 2019-09-17. The firm arranges charter and by-the-seat flights using helicopters, jets, turboprops and amphibious seaplanes operating in various locations throughout the United States and abroad. Its platform utilizes a technology-powered, asset-light business model. The company provides transportation to its customers through a network of contracted aircraft operators. The company operates in three lines of business: Short Distance, MediMobility Organ Transport, and Jet and Other. Short Distance business line consists primarily of helicopter and amphibious seaplane flights in the United States, Canada and France. MediMobility Organ Transport business line consists of the transportation of human organs for transplant. Jet and Other business line consist principally of the non-medical jet charter, by-the-seat jet flights between New York and South Florida, brand partners for exposure to Blade fliers, and ground transportation services.